Prevalence of genital human papillomavirus in suburban women: A systematic review and meta-analysis

Document Type : Review Article


1 PhD Candidate of Reproductive Health, Students Research Committee, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

2 Associate Professor, Midwifery and Reproductive Health Research Center, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

3 Associate Professor, Social Determinants of Health Research Center, Department of Midwifery and Reproductive Health, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.


Introduction: Cervical cancer has been recognized as an important health problem in women. Infection with some genotypes of human papillomavirus (HPV) is the most important risk factor associated with cervical cancer. The present study was conducted with aim to estimate the prevalence of genital HPV in suburban women.
Methods: In this systematic and meta-analysis study from February 20 to March 20, 2023, databases of Web of Science, Scopus, PubMed and Embase and Google scholar search engine were searched without time restrictions using the keywords such as "papillomavirus", "genital wart" and "suburban population" and relevant synonyms. In the selection criteria, observational studies on the prevalence of genital papillomavirus in suburban women were included. Heterogeneity of the studies was evaluated with I2 and Cochran's Q test. Funnel plot and Egger & Begg tests were used to assess the publication bias of the studies.
Results: Finally, 10 studies with a sample size of 65,813 remained in accordance with the purpose of our study. The results of the meta-analysis showed that the overall prevalence of HPV in suburban women was 17% (95% CI: 13-21%) and HPV/16 genotype with a prevalence of 18% (95% CI: 13-23%) was the most common genotype in the affected people.
Conclusion: In general, the prevalence of genital papilloma virus infection was relatively high in suburban women. This result can be useful for policy makers in planning preventive strategies for cervical cancer in poor and low-income environments.


  1. Wang X, Song Y, Wei X, Wang G, Sun R, Wang M, et al. Prevalence and distribution of human papillomavirus genotypes among women attending gynecology clinics in northern Henan Province of China. Virology journal 2022; 19(1):6.
  2. Muñoz-Bello JO, Carrillo-García A, Lizano M. Epidemiology and molecular biology of HPV variants in cervical cancer: The state of the art in Mexico. International Journal of Molecular Sciences 2022; 23(15):8566.
  3. Alarcón-Romero LD, Organista-Nava J, Gómez-Gómez Y, Ortiz-Ortiz J, Hernández-Sotelo D, del Moral-Hernández O, et al. Prevalence and distribution of human papillomavirus genotypes (1997–2019) and their association with cervical cancer and precursor lesions in women from Southern Mexico. Cancer Control 2022; 29:10732748221103331.
  4. Robbins HA, Ferreiro-Iglesias A, Waterboer T, Brenner N, Nygard M, Bender N, et al. Absolute risk of oropharyngeal cancer after an HPV16-E6 serology test and potential implications for screening: results from the human papillomavirus cancer cohort consortium. Journal of Clinical Oncology 2022; 40(31):3613.
  5. Lu Y, Xie Z, Luo G, Yan H, Qian HZ, Fu L, et al. Global burden of oropharyngeal cancer attributable to human papillomavirus by anatomical subsite and geographic region. Cancer Epidemiology 2022; 78:102140.
  6. Skubic L, Hošnjak L, Breznik V, Fujs Komloš K, Luzar B, Poljak M. An Improved Protocol for Comprehensive Etiological Characterization of Skin Warts and Determining Causative Human Papillomavirus Types in 128 Histologically Confirmed Common Warts. Viruses 2022; 14(10):2266.
  7. Abbas KM, van Zandvoort K, Brisson M, Jit M. Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study. The Lancet Global Health 2020; 8(4):e536-44.
  8. Weinberg M, Nahshon CS, Feferkorn I, Bornstein J. Evaluation of human papilloma virus in semen as a risk factor for low sperm quality and poor in vitro fertilization outcomes: a systematic review and meta-analysis. Fertility and Sterility 2020; 113(5):955-69.
  9. Ouh YT, Cho HW, Kim SM, Min KJ, Lee SH, Song JY, et al. Risk factors for type-specific persistence of high-risk human papillomavirus and residual/recurrent cervical intraepithelial neoplasia after surgical treatment. Obstetrics & Gynecology Science 2020; 63(5):631-42.
  10. Yeganeh Z, Sheikhan Z, Kariman N, Esteki T, Dolatian M, Mahmoodi Z, et al. Lifestyle and nutritional risk in women with cervical cancer: A comparative study. International Journal of Women's Health and Reproduction Sciences 2019; 7(4):501-7.
  11. Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, et al. Epidemiology and burden of human papillomavirus and related diseases, molecular pathogenesis, and vaccine evaluation. Frontiers in public health 2021; 8:552028.
  12. Abdi F, Rahnemaei FA, Shojaei P, Afsahi F, Mahmoodi Z. Social determinants of mental health of women living in slum: a systematic review. Obstetrics & Gynecology Science 2021; 64(2):143-55.
  13. Kamara JK, Namugambe BM, Egessa R, Kamanga G, Renzaho AM. The socioeconomic and sexual health status of young people living in urban slum areas of Kampala, Uganda. Journal of Urban Health 2019; 96:616-31.
  14. Saberifar R, Vafayi E. Investigating the impact of Residential Environment in Increasing the Risk of AIDS (Case Study of Mashhad). medical journal of mashhad university of medical sciences 2018; 61(3):1025-35.
  15. Albuquerque A, Cappello C, Stirrup O, Selinger CP. Anal High-risk Human Papillomavirus Infection, Squamous Intraepithelial Lesions, and Anal Cancer in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 2023: jjad045.
  16. Derbie A, Mekonnen D, Nibret E, Maier M, Woldeamanuel Y, Abebe T. Human papillomavirus genotype distribution in Ethiopia: an updated systematic review. Virology journal 2022; 19(1):13.
  17. Sabeena S, Bhat PV, Kamath V, Bhat SK, Nair S, Ravishankar N, et al. Community-based prevalence of genital human papilloma virus (HPV) infection: a systematic review and meta-analysis. Asian Pacific Journal of Cancer Prevention: APJCP 2017; 18(1):145.
  18. Chehreh H, Ozgoli G, Abolmaali K, Nasiri M. The relationship between personality traits and marital satisfaction based on five factors model of personality: A systematic review. Scientific Journal of Kurdistan University of Medical Sciences 2017; 22(5):121-32.
  19. Abdi F, Mahmoodi Z, Afsahi F, Shaterian N, Rahnemaei FA. Social determinants of domestic violence against suburban women in developing countries: a systematic review. Obstetrics & Gynecology Science 2021; 64(2):131-42.
  20. Amponsah-Dacosta E, Kagina BM, Olivier J. Health systems constraints and facilitators of human papillomavirus immunization programmes in sub-Saharan Africa: a systematic review. Health policy and planning 2020; 35(6):701-17.
  21. Munn Z, Moola S, Lisy K, Riitano D, Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. JBI Evidence Implementation 2015; 13(3):147-53.
  22. Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane database of systematic reviews 2019; 2019(10).
  23. Shi X, Nie C, Shi S, Wang T, Yang H, Zhou Y, et al. Effect comparison between Egger’s test and Begg’s test in publication bias diagnosis in meta-analyses: evidence from a pilot survey. Int J Res Stud Biosci 2017; 5(5):14-20.
  24. Zhang R, Shi TY, Ren Y, Lu H, Wei ZH, Hou WJ, et al. Risk factors for human papillomavirus infection in Shanghai suburbs: a population-based study with 10,000 women. Journal of Clinical Virology 2013; 58(1):144-8.
  25. Li C, Wu M, Wang J, Zhang S, Zhu L, Pan J, et al. A population-based study on the risks of cervical lesion and human papillomavirus infection among women in Beijing, People's Republic of China. Cancer epidemiology, biomarkers & prevention 2010; 19(10):2655-64.
  26. Phoolcharoen N, Kantathavorn N, Sricharunrat T, Saeloo S, Krongthong W. A population-based study of cervical cytology findings and human papillomavirus infection in a suburban area of Thailand. Gynecologic oncology reports 2017; 21:73-7.
  27. Velázquez-Márquez N, Jiménez-Aranda LJ, Sánchez-Alonso P, Santos-López G, Reyes-Leyva J, Vallejo-Ruiz V. Human papillomavirus infection in women from Tlaxcala, Mexico. Brazilian Journal of Microbiology 2010; 41:749-56.
  28. Chen Q, Xie LX, Qing ZR, Li LJ, Luo ZY, Lin M, et al. Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China. PloS one 2012; 7(2):e32149.
  29. Isaakidis P, Pimple S, Varghese B, Khan S, Mansoor H, Ladomirska J, et al. HPV infection, cervical abnormalities, and cancer in HIV-infected women in Mumbai, India: 12-month follow-up. International journal of women's health 2013: 487-94.
  30. Lee SH, Vigliotti VS, Pappu S. HPV infection among women in a representative rural and suburban population of the USA. International Journal of Gynecology & Obstetrics 2009; 105(3):210-4.
  31. Datta P, Bhatla N, Dar L, Patro AR, Gulati A, Kriplani A, Singh N. Prevalence of human papillomavirus infection among young women in North India. Cancer epidemiology 2010; 34(2):157-61.
  32. Vora KS, Saiyed S, Joshi R, Natesan S. Prevalence of high‐risk HPV among marginalized urban women in India and its implications on vaccination: A cross sectional study. International Journal of Gynecology & Obstetrics 2023.
  33. Zhang C, Zhang C, Huang J, Wu Z, Mei X, Shi W. Prevalence and genotype distribution of human papillomavirus among females in the suburb of Shanghai, China. Journal of medical virology 2018; 90(1):157-64.
  34. Yadav AK, Jena PK. Maternal health outcomes of socially marginalized groups in India. International Journal of Health Care Quality Assurance 2020; 33(2):172-88.
  35. Afshar N, English DR, Milne RL. Rural–urban residence and cancer survival in high‐income countries: a systematic review. Cancer 2019; 125(13):2172-84.
  36. Khayat S, Dolatian M, Navidian A, Mahmoodi Z, Kasaeian A, Fanaei H. Factors affecting adequacy of prenatal care in suburban women of southeast Iran: a cross-sectional study. Journal of Clinical and Diagnostic Research 2018; 12(4):QC01-QC05.
  37. Obaideen K, Abdelkareem MA, Wilberforce T, Elsaid K, Sayed ET, Maghrabie HM, et al. Biogas role in achievement of the sustainable development goals: Evaluation, Challenges, and Guidelines. Journal of the Taiwan Institute of Chemical Engineers 2022; 131:104207.
  38. Sethi S, Ali A, Ju X, Antonsson A, Logan R, Canfell K, et al. A systematic review and meta-analysis of the prevalence of human papillomavirus infection in Indigenous populations–A Global Picture. Journal of Oral Pathology & Medicine 2021; 50(9):843-54.
  39. Li K, Li Q, Song L, Wang D, Yin R. The distribution and prevalence of human papillomavirus in women in mainland China. Cancer 2019; 125(7):1030-7.
  40. Ardekani A, Sepidarkish M, Mollalo A, Afradiasbagharani P, Rouholamin S, Rezaeinejad M, et al. Worldwide prevalence of human papillomavirus among pregnant women: A systematic review and meta‐analysis. Reviews in Medical Virology 2023; 33(1):e2374.
  41. Kusters JM, Brouwer JG, van Benthem BH, Heijne JC, Schim van der Loeff MF. Global type-specific genital human papillomavirus prevalence in men, by sexual orientation: a systematic review and meta-analysis. The Journal of Infectious Diseases 2023: jiad109.
  42. Li Z, Liu P, Wang Z, Zhang Z, Chen Z, Chu R, et al. Prevalence of human papillomavirus DNA and p16INK4a positivity in vulvar cancer and vulvar intraepithelial neoplasia: a systematic review and meta-analysis. The Lancet Oncology 2023.